Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Reducing Bloodstream Neutrophils as a Treatment for Lung Infection and Inflammation
Case ID:
TAB-3436
Web Published:
12/6/2022
During lung infection, bloodstream neutrophils (PMNs) responding to infection travel to the airspace lumen. Although successful arrival of microbicidal PMNs to the airspace is essential for host defense against inhaled pathogens, excessive accumulation of PMNs in the lung contributes to the pathogenesis of several prevalent lung disorders, including acute lung injury, bronchiectasis, and COPD. Unfortunately, there is no treatment for controlling PMN accumulation in the lung.
NIEHS researchers identified epithelial membrane protein 2 (EMP2) as a lung epithelial protein that regulates PMN entry into the inflamed airspace. EMP2 knockout mice have reduced PMN accumulation and exhibit increased survival during bacterial infection.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Direct Link:
https://canberra-ip.technologypublisher.com/tech/Reducing_Bloodstream_Neutrop hils_as_a_Treatment_for_Lung_Infection_and_Inflammation
Keywords:
2
BARRIER
DA1XXX
DA3XXX
DA4XXX
DAXXXX
DBXXXX
During
DXXXXX
Epithelial
Infection
Inflammation
INTEGRITY
LUNG
MEMBRANE
PROTECT
Protein
respiratory
Targeting
VJXXXX
VKXXXX
VLXXXX
VPXXXX
WBXXXX
WJXXXX
WKXXXX
XAXXXX
YAXXXX
YBXXXX
YCXXXX
Bookmark this page
Download as PDF
For Information, Contact:
Vidita Choudhry
Technology Development Specialist
NIH Technology Transfer
301-594-4095
vidita.choudhry@nih.gov